So Far, So Good

Paris - Citing ease of application and time savings as the key advantages, Jean-Marie Lachapelle, M.D., characterized Allerderm's T.R.U.E. Test as "a step forward in the technology of patch testing that ensures an optimal penetration and delivery of allergens through the skin."

Related Videos
Related Content

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.